We have shown that neuroblastoma tumors with 1p36 deletion have lower UBE4B expression levels, suggesting that decreased UBE4B gene expression is a potential contributor to the poor prognosis of neuroblastoma patients with 1p36 deletions. The gene discussed is UBE4B; the disease is neuroblastoma.